Skip to main content
Search

Article

Preparing your plan for the GLP-1 era

After revolutionizing care for diabetes and weight loss, GLP-1 drugs are being eyed for more. Can we afford it?

Published: July 2024 | 5-minute read

What’s next for GLP-1s?

While GLP-1 drugs were first indicated as a treatment option for type 2 diabetes, recent clinical trials have looked at their use in resolving other issues related to obesity. As these expanded indications emerge, plan sponsors need better-defined strategies – ones that balance cost and utilization.
See what’s coming and how you can prepare.

Gain access to this resource

Please complete the form below to get the insights you're looking for.

Related healthcare insights

E-book

How to contain GLP-1 costs

Get strategies for handling the new anti-obesity medications.

GLP-1 agonists: A new class of weight loss medications

In this conversation, discover how new weight loss drugs like Wegovy are changing obesity management and their connection to diabetes.

Podcast

Pharmacy Insights Podcast

Listen to our resident experts discuss critical industry challenges and the solutions you need to control rising drug costs.